Remdesivir is an experimental antiviral drug, identified by the World Health Organization as one of the most promising treatments in treating COVID-19 positive patients. Only patients with the most severe cases of COVID requiring ventilator support are eligible for this program. St Joe's has registered 16 patients to the trial to date. ###.